IP Library › Granted Patent US 6,900,293
Granted Patent B2
US 6,900,293 · App. 09/734,281 · Granted May 31, 2005

Monoclonal antibodies directed against the microtubule-associated protein tau

Assignee: N.V. Innogenetics S.A.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,900,293
App. No.
09/734,281
Granted
May 31, 2005
Kind
B2
Abstract

A monoclonal antibody which forms an immunological complex with a phosphorylated epitope of an antigen belonging to human abnormally phosphorylated tau protein. The tau protein ca be obtained from a brain homogenate, itself isolated from the cerebral cortex of a patient having Alzheimer's disease.

Claims (12)

1. A monoclonal antibody that forms an immunological complex with a phosphorylated epitope present in a human abnormally phosphorylated tau protein, wherein the phosphorylated epitope is peptide

wherein said peptide is phosphorylated at a position morked with *.

2. A monoclonol antibody that forms an immunological complex with a phosphorylated epitope present in a human abnormally phosphorylated tau protein, wherein the phosphorylated epitope is a peptide

wherein said peptide is phosphorylated at a position marked with *.

3. A monoclonal antibody that forms an immunological complex with a phosphorylated epitope present in a human abnormally phosphorylated tau protein, wherein the phosphorylated epitope is a peptide

wherein said peptide is phosphorylated at a position marked with *.

4. A hybridoma that secrets any one of the monoclonal antibodies of claim 1 , 2 or 3 .

5. A kit comprising: (a) a first monoclonol antibody that forms an immunological complex with a phosphorylated epitope present in a human abnormally phosphorylated tau protein, wherein the phosphorylated epitope is a peptide

wherein said peptide is phosphorylated at a position marked with * and (b) a buffer solution.

6. The kit of claim 5 , further comprising a second antibody that binds either normal tau protein or abnormally phosphorylated tau protein, wherein said second antibody binds an epitope that is different from the first monoclonal antibody and wherein said second antibody is selected from the group consisting of a polyclonal antibody and a monoclonol antibody.

7. The kit of claim 5 , wherein the first monoclonal antibody forms an immunological complex with the phosphorylated epitope of

8. The kit of claim 5 , wherein the first monoclonal antibody forms an immunological complex with the phosphorylated epitope of

Priority Claims (1)
EP 91402871 · Oct 25, 1991 · regional
Continuity (3)
Continuation 0861798700 · Mar 15, 1996
Continuation 0810875800
Related Publication 20010018191A1 · Aug 30, 2001